Chronic Lymphocytic Leukemia (CLL)

Vysis LSI ATM/CEP 11 FISH Probe Kit

For more information, contact Abbott.

Contact
Product Description
RESULTS OF HYBRIDIZATION
Product Description

The Vysis LSI ATM/CEP 11 FISH Probe Kit is intended to detect the copy number of the LSI ATM probe target located at chromosome 11q22.3.

The approximately 732 kb SpectrumOrange LSI ATM probe contains the complete ATM (ataxia telangiectasia mutated) gene and is located at chromosome 11q22.3 (chr11:107306249-108038407 March 2006 UCSC Browser). The SpectrumGreen CEP 11 probe is a control probe which hybridizes to the centromere region of chromosome 11p11.11-q11.

RESULTS OF HYBRIDIZATION
Normal Hybridization: Nucleus showing the two green and two orange signals.
Abnormal Hybridization: Nucleus showing the two green and one orange signal.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No